Pediatrix Medical Group, Inc. Business Combination, Consideration Transferred
Pediatrix Medical Group, Inc. (MD) reported Business Combination, Consideration Transferred of $47.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-18.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2021-02-18
- Pediatrix Medical Group, Inc. business combination, consideration transferred for the quarter ending 2019-12-31 was $15.50M, a 82.27% decline year-over-year.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for the quarter ending 2019-09-30 was $20.00M.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for the quarter ending 2019-06-30 was $7.20M, a 100.00% increase year-over-year.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for the quarter ending 2019-03-31 was $4.30M, a 79.33% decline year-over-year.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for fiscal 2019 was $47.00M, a 57.96% decline from fiscal 2018.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for fiscal 2018 was $111.80M, a 79.82% decline from fiscal 2017.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for fiscal 2017 was $554.00M, a 27.07% decline from fiscal 2016.
- Pediatrix Medical Group, Inc. business combination, consideration transferred for fiscal 2016 was $759.60M, a 10.98% decline from fiscal 2015.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month | Business Combination, Consideration Transferred 12 month | Business Combination, Consideration Transferred 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $35.50M derived: sum of 2 quarters · filed 2021-02-18 | $42.70M derived: sum of 3 quarters · filed 2021-02-18 | $47.00M 10-K · filed 2021-02-18 | $112.00M 10-K · filed 2020-02-20 |
| 2019-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $27.20M derived: sum of 2 quarters · filed 2019-11-01 | $31.50M 10-Q · filed 2019-11-01 | $118.90M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2019-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $11.50M 10-Q · filed 2019-08-01 | $98.90M derived: sum of 3 quarters · filed 2020-02-20 | $98.90M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2019-03-31 | $4.30M 10-Q · filed 2019-05-02 | $91.70M derived: sum of 2 quarters · filed 2020-02-20 | $91.70M derived: sum of 3 quarters · filed 2020-02-20 | $95.30M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-12-31 | $87.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $87.40M derived: sum of 2 quarters · filed 2020-02-20 | $91.00M derived: sum of 3 quarters · filed 2020-02-20 | $111.80M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $3.60M derived: sum of 2 quarters · filed 2018-11-01 | $24.40M 10-Q · filed 2018-11-01 | $221.80M derived: sum of 4 quarters · filed 2018-11-01 | |
| 2018-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $24.40M 10-Q · filed 2018-08-02 | $221.80M derived: sum of 3 quarters · filed 2018-08-02 | $463.20M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2018-03-31 | $20.80M 10-Q · filed 2018-05-04 | $218.20M derived: sum of 2 quarters · filed 2018-05-04 | $459.60M derived: sum of 3 quarters · filed 2018-05-04 | $461.90M derived: sum of 4 quarters · filed 2018-05-04 | |
| 2017-12-31 | $197.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $438.80M derived: sum of 2 quarters · filed 2018-02-14 | $441.10M derived: sum of 3 quarters · filed 2018-02-14 | $554.00M 10-K · filed 2018-02-14 | |
| 2017-09-30 | $241.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $243.70M derived: sum of 2 quarters · filed 2017-11-01 | $356.60M 10-Q · filed 2017-11-01 | $394.00M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2017-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $115.20M 10-Q · filed 2017-07-28 | $152.60M derived: sum of 3 quarters · filed 2018-02-14 | $681.80M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2017-03-31 | $112.90M 10-Q · filed 2017-05-04 | $150.30M derived: sum of 2 quarters · filed 2018-02-14 | $679.50M derived: sum of 3 quarters · filed 2018-02-14 | $815.70M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-12-31 | $37.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $566.60M derived: sum of 2 quarters · filed 2018-02-14 | $702.80M derived: sum of 3 quarters · filed 2018-02-14 | $759.60M 10-K · filed 2018-02-14 | |
| 2016-09-30 | $529.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $665.40M derived: sum of 2 quarters · filed 2016-10-27 | $722.20M 10-Q · filed 2016-10-27 | $734.60M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2016-06-30 | $136.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $193.00M 10-Q · filed 2016-07-28 | $205.40M derived: sum of 3 quarters · filed 2017-02-10 | $450.30M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2016-03-31 | $56.80M 10-Q · filed 2016-04-28 | $69.20M derived: sum of 2 quarters · filed 2017-02-10 | $314.10M derived: sum of 3 quarters · filed 2017-02-10 | $873.00M derived: sum of 4 quarters · filed 2017-02-10 | |
| 2015-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-10 | $257.30M derived: sum of 2 quarters · filed 2017-02-10 | $816.20M derived: sum of 3 quarters · filed 2017-02-10 | $853.30M 10-K · filed 2017-02-10 | |
| 2015-09-30 | $244.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $803.80M derived: sum of 2 quarters · filed 2015-10-29 | $840.90M 10-Q · filed 2015-10-29 | $982.70M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2015-06-30 | $558.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $596.00M 10-Q · filed 2015-07-30 | $737.80M derived: sum of 3 quarters · filed 2016-02-11 | $946.00M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2015-03-31 | $37.10M 10-Q · filed 2015-04-30 | $178.90M derived: sum of 2 quarters · filed 2016-02-11 | $387.10M derived: sum of 3 quarters · filed 2016-02-11 | ||
| 2014-12-31 | $141.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $350.00M derived: sum of 2 quarters · filed 2016-02-11 | $488.60M 10-K · filed 2016-02-11 | ||
| 2014-09-30 | $208.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $346.80M 10-Q · filed 2014-10-30 | |||
| 2014-06-30 | $138.60M 10-Q · filed 2014-07-31 | ||||
| 2013-12-31 | $44.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | $129.30M derived: sum of 2 quarters · filed 2015-02-09 | $250.10M 10-K · filed 2015-02-09 | ||
| 2013-09-30 | $84.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $205.60M 10-Q · filed 2013-10-31 | |||
| 2013-06-30 | $120.80M 10-Q · filed 2013-07-30 | ||||
| 2012-12-31 | $451.10M 10-K · filed 2014-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |